189 related articles for article (PubMed ID: 18957410)
1. Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
Uray IP; Shen Q; Seo HS; Kim H; Lamph WW; Bissonnette RP; Brown PH
J Biol Chem; 2009 Jan; 284(1):345-353. PubMed ID: 18957410
[TBL] [Abstract][Full Text] [Related]
2. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin F; Xiao D; Kolluri SK; Zhang X
Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
[TBL] [Abstract][Full Text] [Related]
3. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
[TBL] [Abstract][Full Text] [Related]
4. Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells.
Shang Y; Baumrucker CR; Green MH
J Biol Chem; 1999 Jun; 274(25):18005-10. PubMed ID: 10364250
[TBL] [Abstract][Full Text] [Related]
5. Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha.
Wu J; Wang H; Tang X
Biochem Biophys Res Commun; 2014 Sep; 452(3):554-9. PubMed ID: 25172665
[TBL] [Abstract][Full Text] [Related]
6. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells.
Wu Q; Chen ZM; Su WJ
Int J Biochem Cell Biol; 2002 Sep; 34(9):1102-14. PubMed ID: 12009305
[TBL] [Abstract][Full Text] [Related]
8. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.
Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH
J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536
[TBL] [Abstract][Full Text] [Related]
9. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
[TBL] [Abstract][Full Text] [Related]
10. The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor.
Li Y; Shen Q; Kim HT; Bissonnette RP; Lamph WW; Yan B; Brown PH
Breast Cancer Res Treat; 2011 Aug; 128(3):667-77. PubMed ID: 20821348
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.
Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV
Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
15. Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Uray IP; Rodenberg JM; Bissonnette RP; Brown PH; Mancini MA
Mol Pharmacol; 2012 Feb; 81(2):228-38. PubMed ID: 22053058
[TBL] [Abstract][Full Text] [Related]
16. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
17. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation by transforming growth factor beta of the expression of retinoic acid and retinoid X receptor genes in osteoblastic cells is mediated through AP-1.
Chen Y; Takeshita A; Ozaki K; Kitano S; Hanazawa S
J Biol Chem; 1996 Dec; 271(49):31602-6. PubMed ID: 8940178
[TBL] [Abstract][Full Text] [Related]
19. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells.
Spanjaard RA; Ikeda M; Lee PJ; Charpentier B; Chin WW; Eberlein TJ
J Biol Chem; 1997 Jul; 272(30):18990-9. PubMed ID: 9228081
[TBL] [Abstract][Full Text] [Related]
20. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
